Novacyt S.A. (NVYTF)
USD 0.54
(0.0%)
USD 0.54
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 11.57 Million GBP | -45.14% |
| 2022 | 21.04 Million GBP | -78.03% |
| 2021 | 95.78 Million GBP | -65.45% |
| 2020 | 277.2 Million GBP | 2380.46% |
| 2019 | 11.17 Million EUR | -9.65% |
| 2018 | 12.36 Million EUR | -6.82% |
| 2017 | 13.27 Million EUR | 40.61% |
| 2016 | 9.44 Million EUR | 43.88% |
| 2015 | 6.56 Million EUR | 85.41% |
| 2014 | 3.53 Million EUR | 251.72% |
| 2013 | 1 Million EUR | 11.56% |
| 2012 | 901.99 Thousand EUR | 18.24% |
| 2011 | 762.83 Thousand EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 5.16 Million GBP | 25.27% |
| 2024 Q2 | 5.16 Million GBP | 0.0% |
| 2023 Q4 | 4.12 Million GBP | 0.0% |
| 2023 FY | 11.54 Million GBP | -45.14% |
| 2023 Q1 | 1.66 Million GBP | -64.08% |
| 2023 Q2 | 3.27 Million GBP | 96.13% |
| 2023 Q3 | 4.12 Million GBP | 25.82% |
| 2022 FY | 21.04 Million GBP | -78.03% |
| 2022 Q1 | 8.25 Million GBP | -80.01% |
| 2022 Q2 | 16.86 Million GBP | 104.37% |
| 2022 Q3 | 2.26 Million GBP | -86.57% |
| 2022 Q4 | 4.64 Million GBP | 105.12% |
| 2021 Q4 | 41.29 Million GBP | 104.42% |
| 2021 FY | 95.78 Million GBP | -65.45% |
| 2021 Q1 | 26.1 Million GBP | -75.6% |
| 2021 Q2 | 53.37 Million GBP | 104.49% |
| 2021 Q3 | 20.2 Million GBP | -62.15% |
| 2020 Q1 | 31.62 Million GBP | 537.2% |
| 2020 Q2 | 65.78 Million GBP | 108.0% |
| 2020 Q3 | 106.97 Million GBP | 62.61% |
| 2020 FY | 277.2 Million GBP | 2380.46% |
| 2020 Q4 | 106.97 Million GBP | 0.0% |
| 2019 FY | 11.17 Million EUR | -9.65% |
| 2019 Q2 | 6.46 Million GBP | 107.79% |
| 2019 Q3 | 2.53 Million GBP | -60.82% |
| 2019 Q1 | 3.11 Million GBP | -48.1% |
| 2019 Q4 | 4.96 Million GBP | 96.01% |
| 2018 Q4 | 5.99 Million GBP | 84.48% |
| 2018 Q2 | 2.84 Million GBP | 0.77% |
| 2018 Q1 | 2.82 Million GBP | 80.64% |
| 2018 FY | 12.36 Million EUR | -6.82% |
| 2018 Q3 | 3.24 Million GBP | 14.27% |
| 2017 Q3 | 3.49 Million GBP | 13.42% |
| 2017 FY | 13.27 Million EUR | 40.61% |
| 2017 Q4 | 1.56 Million GBP | -55.32% |
| 2017 Q2 | 3.08 Million GBP | 2.98% |
| 2017 Q1 | 2.99 Million GBP | 14.39% |
| 2016 FY | 9.44 Million EUR | 43.88% |
| 2016 Q4 | 2.61 Million GBP | -1.43% |
| 2016 Q1 | 1.95 Million GBP | 27.33% |
| 2016 Q2 | 2.06 Million GBP | 5.64% |
| 2016 Q3 | 2.65 Million GBP | 28.37% |
| 2015 Q1 | 1.7 Million GBP | 9.84% |
| 2015 Q3 | 1.53 Million GBP | -7.88% |
| 2015 Q4 | 1.53 Million GBP | -0.14% |
| 2015 FY | 6.56 Million EUR | 85.41% |
| 2015 Q2 | 1.67 Million GBP | -2.04% |
| 2014 Q3 | 1.55 Million GBP | 637.59% |
| 2014 Q4 | 1.55 Million GBP | -0.17% |
| 2014 FY | 3.53 Million EUR | 251.72% |
| 2014 Q2 | 210.9 Thousand GBP | -3.18% |
| 2014 Q1 | 217.82 Thousand GBP | -8.5% |
| 2013 Q1 | 266.81 Thousand GBP | 0.0% |
| 2013 Q3 | 239.4 Thousand GBP | -11.48% |
| 2013 Q4 | 238.06 Thousand GBP | -0.56% |
| 2013 FY | 1 Million EUR | 11.56% |
| 2013 Q2 | 270.45 Thousand GBP | 1.36% |
| 2012 FY | 901.99 Thousand EUR | 18.24% |
| 2011 FY | 762.83 Thousand EUR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Manhattan Scientifics, Inc. | - USD | -Infinity% |
| SS Innovations International, Inc. | 5.87 Million USD | -96.931% |
| Össur hf. | 785.68 Million USD | 98.526% |
| Össur hf. | 785.68 Million USD | 98.526% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| QHSLab, Inc. | 1.4 Million USD | -721.791% |
| BrainsWay Ltd. | 31.78 Million USD | 63.571% |
| BioElectronics Corporation | 714.7 Thousand USD | -1520.102% |
| AVITA Medical, Inc. | 50.56 Million USD | 77.099% |
| Zecotek Photonics Inc. | 86.61 Thousand USD | -13269.126% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| Wellstar International, Inc. | - USD | -Infinity% |
| Hamilton Thorne Ltd. | 68.45 Million USD | 83.086% |
| EKF Diagnostics Holdings plc | 52.61 Million USD | 77.991% |
| Escalon Medical Corp. | 11.98 Million USD | 3.359% |
| Aurora Spine Corporation | 14.52 Million USD | 20.257% |
| NewCardio, Inc. | 257.39 Thousand USD | -4398.463% |
| Avitar, Inc. | 3.1 Million USD | -272.767% |
| Vivos Inc. | 19.5 Thousand USD | -59279.487% |
| Theraclion SA | 1.82 Million USD | -535.433% |
| Kelyniam Global, Inc. | 2.67 Million USD | -333.288% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| REMSleep Holdings, Inc. | 203.71 Thousand USD | -5583.837% |
| Positron Corporation | 734.66 Thousand USD | -1476.09% |
| CYduct Diagnostics, Inc. | 84.48 Thousand USD | -13605.554% |
| Nanomix Corporation | 15.45 Thousand USD | -74844.984% |
| Wellness Center USA, Inc. | 661.55 Thousand USD | -1650.283% |
| Stratec SE | 289.14 Million USD | 95.995% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.34 Million USD | -758.462% |
| Lombard Medical, Inc. | 12.16 Million USD | 4.848% |
| ALR Technologies Inc. | 7468.00 USD | -154948.206% |
| MicroPort Scientific Corporation | 950.72 Million USD | 98.782% |
| Vycor Medical, Inc. | 1.46 Million USD | -692.754% |
| VMS Rehab Systems, Inc. | 71.70 USD | -16149132.915% |
| Perimeter Medical Imaging AI, Inc. | 403.53 Thousand USD | -2769.406% |
| Guided Therapeutics, Inc. | 98 Thousand USD | -11715.306% |
| SANUWAVE Health, Inc. | 20.39 Million USD | 43.235% |
| Ingen Technologies, Inc. | 720.67 Thousand USD | -1506.681% |
| United American Healthcare Corporation | - USD | -Infinity% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| IR-Med Inc. | - USD | -Infinity% |
| Polarean Imaging plc | 890.93 Thousand USD | -1199.649% |
| ECGI Holdings, Inc. | - USD | -Infinity% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 2.84 Million USD | -306.957% |
| Medical Supply International USA, Inc. | 2.81 Million USD | -310.984% |
| Urologix, Inc. | 14.23 Million USD | 18.658% |
| Rapid Therapeutic Science Laboratories, Inc. | - USD | -Infinity% |
| Nexeon MedSystems Inc. | 3.3 Million USD | -250.584% |
| Qualis Innovations, Inc. | 40.17 Thousand USD | -28721.406% |
| Smith & Nephew plc | 5.68 Billion USD | 99.796% |
| NIOX Group Plc | 46.84 Million USD | 75.283% |
| Fuse Medical, Inc. | 16.11 Million USD | 28.15% |
| Broncus Holding Corporation | 10.25 Million USD | -12.911% |
| Brain Scientific Inc. | 214.56 Thousand USD | -5296.525% |
| Pressure BioSciences, Inc. | 1.97 Million USD | -485.459% |
| Health Logic Interactive Inc. | - USD | -Infinity% |